Pathstone Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,363
| Closed | -$436K | – | 2328 |
|
|
2024
Q4 | $436K | Sell |
10,363
-552
| -5% | -$23.2K | ﹤0.01% | 1786 |
|
|
2024
Q3 | $606K | Buy |
10,915
+1,749
| +19% | +$97.2K | ﹤0.01% | 1629 |
|
|
2024
Q2 | $377K | Buy |
9,166
+3,998
| +77% | +$164K | ﹤0.01% | 1835 |
|
|
2024
Q1 | $241K | Buy |
+5,168
| New | +$241K | ﹤0.01% | 2040 |
|